Evidence map›Paper›PMID 34324513›Full record

ArticlePloS one2021

Prevalence of stroke survival in rural communities living in northern Peru.

Luz M Moyano, Silvia M Montano, Percy Vilchez Barreto, Narcisa Reto, Luis Larrauri, Nicanor Mori, Mario Cornejo-Olivas, Erik Guevara-Silva, Fernando Urizar, Enrique Najar and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Luz M MoyanoCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.ORCID 0000-0002-5878-5782
Silvia M MontanoSección de Epidemiologia, Instituto de Medicina Tropical Daniel Alcides carrión Universidad Nacional Mayor de San Marcos, Lima, Perú.
Percy Vilchez BarretoCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Narcisa RetoCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.ORCID 0000-0002-8107-1657
Luis LarrauriCentro Basico de Investigación en Demencia y enfermedades desmielinizantes, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Nicanor MoriDepartamento de Medicina, Hospital Nacional Daniel Alcides Carriòn, Lima, Perú.ORCID 0000-0002-2270-1663
Mario Cornejo-OlivasCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Erik Guevara-SilvaCentro Basico de Investigación en Demencia y enfermedades desmielinizantes, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Fernando UrizarCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Enrique NajarDepartamento de Medicina, Hospital Nacional Cayetano Heredia, Lima, Perú.
Ricardo GamboaCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Cintya AzabacheCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Raquel Herrer TicseCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Lucia Bolivar-HerradaCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Alex DoudDepartments of Neurology, Global Health, Medicine and Epidemiology, University of Washington, Seattle, WA, United State of America.
Peggy MartinezDepartamento de Pediatría, Instituto Nacional del Niño, San Borja, Lima, Perú.
J Jaime MirandaCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Joseph R ZuntDepartamento de Medicina, Hospital Nacional Cayetano Heredia, Lima, Perú.
Hector H GarcíaCysticercosis Elimination Program, Center for Global Health, Universidad Peruana Cayetano Heredia, Tumbes, Perú.
Cysticercosis Working Group for Peru
Universidad Peruana Cayetano Heredia · PEHospital Nacional Cayetano Heredia · PEInstituto Nacional de Enfermedades Neoplásicas · PEDaniel Alcides Carrión National University · PEInstituto Nacional de Salud del Niño · PENational University of San Marcos · PEUniversity of Washington · US

Funding

NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Training in Parasitic Diseases and Central Nervous System Infections in Peru.D43TW001140 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO, GILMAN, ROBERT H · 1999 to 2025
$5.7M
Interdisciplinary Cerebrovascular Diseases Training Program in South AmericaD43TW009137 · FIC · UNIVERSITY OF WASHINGTON · PI GARCIA, HECTOR HUGO, TIRSCHWELL, DAVID L · 2014 to 2023
$2.6M
FIC NIH HHS D43 TW001140FIC NIH HHS D43 TW009137FIC NIH HHS D43 TW009345
6 · The paper itself

Abstract

background and purposeStroke is the leading cause of neurological impairment in the South American Andean region. However, the epidemiology of stroke in the region has been poorly characterized.

methodsWe conducted a staged three-phase population-based study applying a validated eight-question neurological survey in 80 rural villages in Tumbes, northern Peru, then confirmed presence or absence of stroke through a neurologist's examination to estimate the prevalence of stroke.

resultsOur survey covered 90% of the population (22,278/24,854 individuals, mean age 30±21.28, 48.45% females), and prevalence of stroke was 7.05/1,000 inhabitants. After direct standardization to WHO's world standard population, adjusted prevalence of stroke was 6.94/1,000 inhabitants. Participants aged ≥85 years had higher stroke prevalence (>50/1000 inhabitants) compared to other stratified ages, and some unusual cases of stroke were found among individuals aged 25-34 years. The lowest age reported for a first stroke event was 16.8 years. High blood pressure (aPR 4.2 [2.7-6.4], p>0.001), and sedentary lifestyle (aPR 1.6 [1.0-2.6], p = 0.045) were more prevalent in people with stroke.

conclusionsThe age-standardized prevalence of stroke in this rural coastal Peruvian population was slightly higher than previously reported in studies from surrounding rural South American settings, but lower than in rural African and Asian regions. The death rate from stroke was much higher than in industrialized and middle-income countries.

Indexed as

Rural PopulationStrokeAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansMaleMiddle AgedPeruPrevalenceRisk FactorsYoung Adult

Identifiers

PMID34324513
PMCPMC8321101
OpenAlexW3184013415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.